Year |
Citation |
Score |
2010 |
Passic SR, Ferguson ML, Catalone BJ, Kish-Catalone T, Kholodovych V, Zhu W, Welsh W, Rando R, Howett MK, Wigdahl B, Labib M, Krebs FC. Structure-activity relationships of polybiguanides with activity against human immunodeficiency virus type 1 Biomedicine and Pharmacotherapy. 64: 723-732. PMID 21106331 DOI: 10.1016/J.Biopha.2010.10.001 |
0.556 |
|
2006 |
Beer BE, Doncel GF, Krebs FC, Shattock RJ, Fletcher PS, Buckheit RW, Watson K, Dezzutti CS, Cummins JE, Bromley E, Richardson-Harman N, Pallansch LA, Lackman-Smith C, Osterling C, Mankowski M, ... ... Catalone BJ, et al. In vitro preclinical testing of nonoxynol-9 as potential anti-human immunodeficiency virus microbicide: a retrospective analysis of results from five laboratories. Antimicrobial Agents and Chemotherapy. 50: 713-23. PMID 16436731 DOI: 10.1128/Aac.50.2.713-723.2006 |
0.603 |
|
2005 |
Catalone BJ, Miller SR, Ferguson ML, Malamud D, Kish-Catalone T, Thakkar NJ, Krebs FC, Howett MK, Wigdahl B. Toxicity, inflammation, and anti-human immunodeficiency virus type 1 activity following exposure to chemical moieties of C31G. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 59: 430-7. PMID 16154721 DOI: 10.1016/J.Biopha.2005.07.008 |
0.621 |
|
2005 |
Catalone BJ, Ferguson ML, Miller SR, Malamud D, Kish-Catalone T, Thakkar NJ, Krebs FC, Howett MK, Wigdahl B. Prolonged exposure to the candidate microbicide C31G differentially reduces cellular sensitivity to agent re-exposure. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 59: 460-8. PMID 16154719 DOI: 10.1016/J.Biopha.2005.07.009 |
0.593 |
|
2005 |
Catalone BJ, Kish-Catalone TM, Neely EB, Budgeon LR, Ferguson ML, Stiller C, Miller SR, Malamud D, Krebs FC, Howett MK, Wigdahl B. Comparative safety evaluation of the candidate vaginal microbicide C31G. Antimicrobial Agents and Chemotherapy. 49: 1509-20. PMID 15793133 DOI: 10.1128/Aac.49.4.1509-1520.2005 |
0.557 |
|
2004 |
Catalone BJ, Kish-Catalone TM, Budgeon LR, Neely EB, Ferguson M, Krebs FC, Howett MK, Labib M, Rando R, Wigdahl B. Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicides. Antimicrobial Agents and Chemotherapy. 48: 1837-47. PMID 15105142 DOI: 10.1128/Aac.48.5.1837-1847.2004 |
0.658 |
|
2004 |
Kensinger RD, Catalone BJ, Krebs FC, Wigdahl B, Schengrund CL. Novel polysulfated galactose-derivatized dendrimers as binding antagonists of human immunodeficiency virus type 1 infection. Antimicrobial Agents and Chemotherapy. 48: 1614-23. PMID 15105112 DOI: 10.1128/Aac.48.5.1614-1623.2004 |
0.538 |
|
2002 |
Krebs FC, Miller SR, Catalone BJ, Fichorova R, Anderson D, Malamud D, Howett MK, Wigdahl B. Comparative in vitro sensitivities of human immune cell lines, vaginal and cervical epithelial cell lines, and primary cells to candidate microbicides nonoxynol 9, C31G, and sodium dodecyl sulfate. Antimicrobial Agents and Chemotherapy. 46: 2292-8. PMID 12069993 DOI: 10.1128/Aac.46.7.2292-2298.2002 |
0.58 |
|
2000 |
Krebs FC, Miller SR, Catalone BJ, Welsh PA, Malamud D, Howett MK, Wigdahl B. Sodium dodecyl sulfate and C31G as microbicidal alternatives to nonoxynol 9: comparative sensitivity of primary human vaginal keratinocytes. Antimicrobial Agents and Chemotherapy. 44: 1954-60. PMID 10858360 DOI: 10.1128/Aac.44.7.1954-1960.2000 |
0.632 |
|
Show low-probability matches. |